GHSI:NSD-Guardion Health Sciences Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 6.55

Change

-3.97 (-37.74)%

Market Cap

USD 0.01B

Volume

0.38M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.10 (+0.05%)

USD 89.02B
HLN Haleon plc

+0.03 (+0.28%)

USD 48.04B
TAK Takeda Pharmaceutical Co Ltd A..

-0.09 (-0.60%)

USD 47.42B
HNSPF Hansoh Pharmaceutical Group Co..

N/A

USD 13.26B
RDY Dr. Reddy’s Laboratories Ltd..

+0.12 (+0.15%)

USD 13.05B
CTLT Catalent Inc

+0.39 (+0.65%)

USD 10.91B
ELAN Elanco Animal Health

-0.56 (-3.88%)

USD 6.96B
BHC Bausch Health Companies Inc

+0.07 (+0.87%)

USD 2.97B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.08 (-0.94%)

USD 2.61B
CPHI China Pharma Holdings Inc

+0.01 (+2.86%)

USD 3.66M

ETFs Containing GHSI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.66% 69% C- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.66% 69% C- 80% B-
Trailing 12 Months  
Capital Gain -13.77% 25% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.77% 19% F 11% F
Trailing 5 Years  
Capital Gain -97.04% 20% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -97.04% 20% F 1% F
Average Annual (5 Year Horizon)  
Capital Gain 234.28% 94% A 97% N/A
Dividend Return 234.28% 94% A 97% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3,005.46% 8% B- 2% F
Risk Adjusted Return 7.80% 62% D 44% F
Market Capitalization 0.01B 25% F 9% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.